top of page

BackTable / VI / Contributor

Dr. Nicholas Fidelman on the BackTable VI Podcast

Dr. Nicholas Fidelman

Interventional Radiologist

Dr. Nicholas Fidelman is an interventional radiologist and the director of Interventional Oncology at UCSF in San Francisco.

Listen to Dr. Nicholas Fidelman on the BackTable Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Nicholas Fidelman and get practical advice on how to build your practice by listening to the BackTable Podcast.

Ep 256 Origins of TACE with Dr. Michael Soulen and Dr. Nicholas Fidelman
00:00 / 01:04

Stay Up To Date

Follow:

Subscribe:

Sign Up:

About Dr. Nicholas Fidelman

Dr. Nicholas Fidelman is a radiologist who specializes in caring for patients with liver cancer, metastatic colorectal cancer and neuroendocrine tumors. He has expertise in liver-directed therapy, a treatment that directly targets cancer in the liver. He also is experienced in treating portal hypertension (high blood pressure in the veins connecting the digestive organs to the liver), biliary disorders (which affect the bile ducts and gallbladder), urinary system disorders, and in performing dialysis interventions (minimally invasive procedures to restore blood flow in vessels used for dialysis).

Fidelman's research focuses on clinical trials investigating novel treatments for liver cancer, outcomes of commonly performed procedures in interventional radiology, and on improving the safety and efficacy of image-guided treatments.

Fidelman earned his medical degree from UCSF, where he also completed a residency in radiology and a fellowship in vascular and interventional radiology.

Podcasts Featuring Dr. Nicholas Fidelman

VI

VI Episode #256

In this episode, guest host Dr. Nicholas Fidelman interviews Dr. Michael Soulen, a key player in the development and widespread adoption of transarterial chemoembolization (TACE). The doctors discuss how TACE became a major therapeutic option for liver tumors, his preferred method of TACE dosage and management, and exciting new frontiers in chemoembolization.

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg

Podcasts

Origins of TACE with Dr. Michael Soulen and Dr. Nicholas Fidelman on the BackTable VI Podcast
Multidisciplinary HCC Care: Improving the Patient Experience with Combined Clinics with Dr. Tyler Sandow, Dr. Jonathan Mizrahi, Dr. Steven Young and Deondra Bonds-Adams on the BackTable VI Podcast

Topics

Hepatocellular Carcinoma (HCC) Podcasts
Interventional Oncology (IO) Podcasts
Transarterial Chemoembolization (TACE) Podcasts
Y90 Radioembolization Podcasts

More Contributors

Dr. Jason Abel on the BackTable VI Podcast

Dr. Jason Abel

Dr. Nabil Adra on the BackTable Urology Podcast

Dr. Nabil Adra

Dr. Ashley Agan on the BackTable ENT Podcast

Dr. Ashley Agan

Dr. Neeraj Agarwal on the BackTable Urology Podcast

Dr. Neeraj Agarwal

Dr. Piyush Agarwal on the BackTable Urology Podcast

Dr. Piyush Agarwal

Dr. Altan Ahmed on the BackTable VI Podcast

Dr. Altan Ahmed

bottom of page